Abstracts

510 – A Novel and Promising Strategy of HIV Eradication via LTR-LTR Recombination

Background Long-lived HIV-infected cells persist and undergo clonal expansion, preventing viral eradication during antiretroviral therapy. The majority of infected cells contain defective proviruses with mutations, deletions, or insertions. Defective proviruses are also generated by LTR-LTR recombination, excising the entire coding sequence, leaving only a solo LTR at the integration site. Little is known regarding solo…

590 – Evaluating White Matter Integrity in Relation to HIV Severity and Cognitive Impairment

Background Though incurable, HIV has become widely treatable with combination antiretroviral therapy (cART), significantly extending the lifespan of people living with HIV (PLWH). This has resulted in an aging PLWH population facing growing concerns for age-associated HIV comorbidities such as cognitive impairment (CI), which remains equally prevalent and relevant for PLWH in the cART era.…

520 – Well-Seeded Reservoirs in Gut Are Associated With Tertiary Lymphoid Structures With Activated ISR

Background Despite effective antiretroviral therapy (ART), HIV-1 persistence is the major obstacle to a functional cure. Thus, understanding the tissue microenvironment during ART of the reservoirs that lead to a rapid viral rebound after treatment failure or analytical treatment interruption (ATI) is key.  Methods We have developed immunoPET/CT-guided spatial transcriptomics, combined with immunofluorescence detection of…

465 – Lymph Node Dendritic Cells Harbor an Altered Transcriptomic Profile Despite Years of Suppressive ART

Background Despite significant advances in the efficacy of antiretroviral therapy (ART) and expanded access to people living with HIV, virologic suppression through ART alone is frequently insufficient to fully resolve the immune activation associated with HIV infection.  Methods We evaluated the influence of HIV infection on the functional and transcriptomic profile of lymph node (LN) myeloid dendritic…

486 – Consecutive Analytical Treatment Interruption Improves CD8 T-Cell Activity During Viral Control

Background In the PULSE clinical trial, 68 people living with HIV underwent three consecutive analytical treatment interruptions (ATIs). Of note, 10% of the participants transiently controlled HIV rebound during the 3rd ATI. We investigated whether this virological control is associated with improved antiviral CD8 T-cell function and response to mutationally-constrained and highly-conserved HIV epitopes. Methods…

626 – Increased Cerebral Arterial Transit Time in Obese Females With HIV and Metabolic Syndrome

Background The prevalence of obesity, and subsequent metabolic syndrome (MetS), is increasing in persons living with HIV (PLWH) on antiretroviral therapy (ART), with nearly 1 in 4 meeting MetS criteria. African females with HIV are at particular risk of developing obesity complicated by MetS. Obesity increases the risk of cardiovascular and cerebrovascular disease. There is…

436 – Incidence and Predictors of STIs and Effect on Immune Activation in the HVTN 705/HPX2008 Trial

Background STIs are common among participants participating in HIV vaccine trials. STIs may lead to proliferated immune responses, which could affect immune responses induced by HIV vaccines.  Methods We conducted a secondary analysis of HVTN 705/HPX2008, a phase 2b placebo-controlled efficacy trial of Ad26.Mos4.HIV and aluminum phosphate-adjuvanted clade C gp140 in preventing HIV-1 infection in…

615 – Neuronal Injury in a Subset of PWH During Acute HIV Infection and Up to 5 Years After Immediate ART

Background Neurofilament light chain (NFL) is a sensitive neuronal injury marker, with levels elevated in both neuroinflammatory and neurodegenerative diseases. Cerebrospinal fluid (CSF) NFL is elevated in up to 40% of people with HIV during the 1st year of infection and has been reported as normalizing after antiretroviral therapy (ART). We measured CSF NFL cross-sectionally during…